This inventor holds 2 USPTO granted patents. Top assignees: Battelle Memorial Institute, Idaho Research Foundation, Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Moscow, ID (US) (2000)
- Syracuse, NY (US) (2000)
Company Filing History:


Years Active: 2000
Title: Innovations of Xiaoyuan Chen in Radionuclide Delivery Systems
Introduction
Xiaoyuan Chen is an accomplished inventor based in Moscow, ID (US). He has made significant contributions to the field of radionuclide-binding compounds and delivery systems. With a total of 2 patents, his work focuses on innovative methods for binding and delivering radionuclides.
Latest Patents
Xiaoyuan Chen's latest patents include a radionuclide-binding compound and a radionuclide delivery system. The invention pertains to compounds that specifically bind radionuclides and methods for creating radionuclide complexing compounds. One aspect of his invention includes a radionuclide delivery system that comprises a calix[n]arene-crown-[m]-ether compound, which features at least two ionizable groups and an antibody attached to it. Another aspect involves a method for making a radium complexing compound, detailing a series of chemical reactions to create a calix[n]arene-crown-[m]-ether compound.
Career Highlights
Xiaoyuan Chen has worked with notable organizations such as Battelle Memorial Institute and Idaho Research Foundation, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of radionuclide chemistry.
Collaborations
Some of his notable coworkers include Chien M Wai and Darrell R Fisher. Their collaborative efforts have contributed to the advancement of research in radionuclide applications.
Conclusion
Xiaoyuan Chen's innovative work in radionuclide-binding compounds and delivery systems showcases his expertise and dedication to advancing scientific knowledge. His contributions are significant in the field of chemistry and have the potential to impact various applications in medicine and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile